This is a conversation about synthetic biology. What's needed to jump from the laboratory to the factory floor? My guest is Joshua Lachter, the co-founder and chief business officer for Synonym, a New York based company financing and helping source production capacity for synthetic biology companies. Joshua and I take a pretty broad based hike into synthetic biology. What is it? How do we use it today? What's the core science? What opportunities ahead, and what challenges must be overcome to get there? Dig in.